Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Adaptive threshold-stochastic resonance (AT-SR) in MHC clusters on the cell surface.

Bene L, Bagdány M, Damjanovich L.

Immunol Lett. 2019 Nov 15;217:65-71. doi: 10.1016/j.imlet.2019.11.006. [Epub ahead of print] Review.

PMID:
31738956
2.

Förster Resonance Energy Transfer Pioneers Biomechanics: Molecular-Scale Force Meters for Visualizing Intracellular Stress Fields.

Bene L, Damjanovich L.

Cytometry A. 2019 Aug;95(8):819-822. doi: 10.1002/cyto.a.23780. Epub 2019 Apr 29. No abstract available.

PMID:
31034713
3.

Dual-Laser Tetra-Polarization FRET (4polFRET) for Site-Selective Control of Homo-FRET in Hetero-FRET Systems on the Cell Surface: The Homo-FRET Gate.

Bene L, Bagdány M, Ungvári T, Damjanovich L.

Anal Chem. 2018 Sep 4;90(17):10159-10170. doi: 10.1021/acs.analchem.7b05441. Epub 2018 Aug 22.

PMID:
30080974
4.

Checkpoint for helicity conservation in fluorescence at the nanoscale: Energy and helicity transfer (hFRET) from a rotating donor dipole.

Bene L, Bagdány M, Damjanovich L.

Biophys Chem. 2018 Aug;239:38-53. doi: 10.1016/j.bpc.2018.05.002. Epub 2018 May 22.

PMID:
29807308
5.

Turning noise into order on the cell surface: Resonant activation of molecular highlighters.

Vámosi G, Damjanovich L, Bene L.

Cytometry A. 2018 Apr;93(4):397-401. doi: 10.1002/cyto.a.23320. Epub 2018 Feb 1. No abstract available.

6.

Confocal microscopic dual-laser dual-polarization FRET (2polFRET) at the acceptor side for correlating rotations at different distances on the cell surface.

Bene L, Gralle M, Damjanovich L.

Biochim Biophys Acta Gen Subj. 2018 Apr;1862(4):1050-1068. doi: 10.1016/j.bbagen.2017.12.013. Epub 2017 Dec 30.

PMID:
29292190
7.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.

Gonczi L, Gecse KB, Vegh Z, Kurti Z, Rutka M, Farkas K, Golovics PA, Lovasz BD, Banai J, Bene L, Gasztonyi B, Kristof T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai A, Salamon A, Szamosi T, Szepes Z, Toth GT, Vincze A, Szalay B, Molnar T, Lakatos PL.

Inflamm Bowel Dis. 2017 Nov;23(11):1908-1915. doi: 10.1097/MIB.0000000000001237.

PMID:
28922253
8.

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.

Bálint A, Rutka M, Végh Z, Kürti Z, Gecse KB, Banai J, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Patai Á, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Bor R, Milassin Á, Fábián A, Nagy F, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Lakatos PL, Molnár T, Farkas K.

Expert Opin Drug Saf. 2017 Aug;16(8):885-890. doi: 10.1080/14740338.2017.1323330. Epub 2017 May 26.

PMID:
28504555
9.

Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity.

Kocsmár É, Szirtes I, Kramer Z, Szijártó A, Bene L, Buzás GM, Kenessey I, Bronsert P, Csanadi A, Lutz L, Werner M, Wellner UF, Kiss A, Schaff Z, Lotz G.

Helicobacter. 2017 Aug;22(4). doi: 10.1111/hel.12387. Epub 2017 Apr 12.

PMID:
28402048
10.

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Gonczi L, Vegh Z, Golovics PA, Rutka M, Gecse KB, Bor R, Farkas K, Szamosi T, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Papp M, Patai Á, Salamon Á, Tóth GT, Vincze Á, Biro E, Lovasz BD, Kurti Z, Szepes Z, Molnár T, Lakatos PL.

J Crohns Colitis. 2017 Jun 1;11(6):697-705. doi: 10.1093/ecco-jcc/jjw203.

PMID:
27838610
11.

[Invasive methods in the treatment of obesity].

Bene L.

Orv Hetil. 2016 May 8;157(19):728-32. doi: 10.1556/650.2016.30438. Review. Hungarian.

PMID:
27133271
12.

Perrin and Förster unified: Dual-laser triple-polarization FRET (3polFRET) for interactions at the Förster-distance and beyond.

Ungvári T, Gogolák P, Bagdány M, Damjanovich L, Bene L.

Biochim Biophys Acta. 2016 Apr;1863(4):703-16. doi: 10.1016/j.bbamcr.2016.02.002. Epub 2016 Feb 6.

13.

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.

Gecse KB, Lovász BD, Farkas K, Banai J, Bene L, Gasztonyi B, Golovics PA, Kristóf T, Lakatos L, Csontos ÁA, Juhász M, Nagy F, Palatka K, Papp M, Patai Á, Lakner L, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Szalay B, Molnár T, Lakatos PL.

J Crohns Colitis. 2016 Feb;10(2):133-40. doi: 10.1093/ecco-jcc/jjv220. Epub 2015 Dec 10.

PMID:
26661272
14.

Depolarized FRET (depolFRET) on the cell surface: FRET control by photoselection.

Bene L, Gogolák P, Ungvári T, Bagdány M, Nagy I, Damjanovich L.

Biochim Biophys Acta. 2016 Feb;1863(2):322-34. doi: 10.1016/j.bbamcr.2015.12.003. Epub 2015 Dec 3.

15.

Dual-laser homo-FRET on the cell surface.

Bene L, Ungvári T, Fedor R, Nagy I, Damjanovich L.

Biochim Biophys Acta. 2015 May;1853(5):1096-112. doi: 10.1016/j.bbamcr.2015.02.001. Epub 2015 Feb 8.

16.

The other side of the coin: time-domain fluorescence lifetime in flow.

Bene L, Damjanovich L.

Cytometry A. 2015 Feb;87(2):101-3. doi: 10.1002/cyto.a.22615. Epub 2014 Dec 16. No abstract available.

17.

À la Fizeau in flow: pulse shape-assisted fluorescence lifetime.

Bene L, Szöllősi J.

Cytometry A. 2014 Dec;85(12):991-4. doi: 10.1002/cyto.a.22583. Epub 2014 Nov 5. Review. No abstract available.

18.

Single-laser polarization FRET (polFRET) on the cell surface.

Bene L, Ungvári T, Fedor R, Damjanovich L.

Biochim Biophys Acta. 2014 Dec;1843(12):3047-64. doi: 10.1016/j.bbamcr.2014.07.011. Epub 2014 Sep 18.

19.

Intensity correlation-based calibration of FRET.

Bene L, Ungvári T, Fedor R, Sasi Szabó L, Damjanovich L.

Biophys J. 2013 Nov 5;105(9):2024-35. doi: 10.1016/j.bpj.2013.09.041.

20.

Oxonol has the potential to probe membrane fields.

Bene L.

Cytometry A. 2013 Jul;83(7):608-11. doi: 10.1002/cyto.a.22314. No abstract available.

21.

Devastating decline of forest elephants in central Africa.

Maisels F, Strindberg S, Blake S, Wittemyer G, Hart J, Williamson EA, Aba'a R, Abitsi G, Ambahe RD, Amsini F, Bakabana PC, Hicks TC, Bayogo RE, Bechem M, Beyers RL, Bezangoye AN, Boundja P, Bout N, Akou ME, Bene LB, Fosso B, Greengrass E, Grossmann F, Ikamba-Nkulu C, Ilambu O, Inogwabini BI, Iyenguet F, Kiminou F, Kokangoye M, Kujirakwinja D, Latour S, Liengola I, Mackaya Q, Madidi J, Madzoke B, Makoumbou C, Malanda GA, Malonga R, Mbani O, Mbendzo VA, Ambassa E, Ekinde A, Mihindou Y, Morgan BJ, Motsaba P, Moukala G, Mounguengui A, Mowawa BS, Ndzai C, Nixon S, Nkumu P, Nzolani F, Pintea L, Plumptre A, Rainey H, de Semboli BB, Serckx A, Stokes E, Turkalo A, Vanleeuwe H, Vosper A, Warren Y.

PLoS One. 2013;8(3):e59469. doi: 10.1371/journal.pone.0059469. Epub 2013 Mar 4.

22.
23.

The increasing labor force participation of older workers and its effect on the income of the aged.

Leonesio MV, Bridges B, Gesumaria R, Del Bene L.

Soc Secur Bull. 2012;72(1):59-77.

PMID:
22550721
24.

Crohn's disease alters MHC-rafts in CD4+ T-cells.

Damjanovich L, Volkó J, Forgács A, Hohenberger W, Bene L.

Cytometry A. 2012 Feb;81(2):149-64. doi: 10.1002/cyto.a.21173. Epub 2011 Nov 29.

25.

Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease.

Füst G, Uray K, Bene L, Hudecz F, Karádi I, Prohászka Z.

Cell Stress Chaperones. 2012 Mar;17(2):215-27. doi: 10.1007/s12192-011-0301-7. Epub 2011 Oct 29.

26.

Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

Bene L, Falus A, Baffy N, Fulop AK.

Pathol Oncol Res. 2011 Sep;17(3):463-72. doi: 10.1007/s12253-011-9397-4. Epub 2011 Jun 17. Review.

PMID:
21681604
27.

The distribution of annual and long-run U.S. earnings, 1981-2004.

Leonesio MV, Del Bene L.

Soc Secur Bull. 2011;71(1):17-33.

PMID:
21466032
28.

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.

Lakatos PL, Czegledi Z, David G, Kispal Z, Kiss LS, Palatka K, Kristof T, Nagy F, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, Kovacs A, Racz I, Lakatos L.

J Crohns Colitis. 2010 Sep;4(3):283-90. doi: 10.1016/j.crohns.2009.11.011.

PMID:
21122517
29.

[Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].

Lakatos L, Czeglédi Z, Dávid G, Kispál Z, Kiss LS, Palatka K, Kristóf T, Molnár T, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, Kovács A, Rácz I, Lakatos PL.

Orv Hetil. 2010 Feb 14;151(7):250-8. doi: 10.1556/OH.2010.28805. Hungarian.

PMID:
20133244
30.

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.

Reinisch W, de Villiers W, Bene L, Simon L, Rácz I, Katz S, Altorjay I, Feagan B, Riff D, Bernstein CN, Hommes D, Rutgeerts P, Cortot A, Gaspari M, Cheng M, Pearce T, Sands BE.

Inflamm Bowel Dis. 2010 Feb;16(2):233-42. doi: 10.1002/ibd.21038.

PMID:
19637334
31.

Colorectal carcinoma rearranges cell surface protein topology and density in CD4+ T cells.

Bene L, Kanyári Z, Bodnár A, Kappelmayer J, Waldmann TA, Vámosi G, Damjanovich L.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):202-7. Epub 2007 Jul 16.

PMID:
17658476
32.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J; Hungarian IBD Study Group, Lakatos PL.

Inflamm Bowel Dis. 2007 Aug;13(8):984-92.

PMID:
17417801
33.

Combination of all-trans-retinoic acid and gemtuzumab ozogamicin in an elderly patient with acute promyelocytic leukemia and severe cardiac failure.

Finizio O, Pezzullo L, Rocco S, Bene L, De Rosa C, Nunziata GR, Mettivier V.

Acta Haematol. 2007;117(3):188-90. Epub 2006 Dec 13.

PMID:
17167240
34.

Two-dimensional receptor patterns in the plasma membrane of cells. A critical evaluation of their identification, origin and information content.

Damjanovich S, Bene L, Matkó J, Mátyus L, Krasznai Z, Szabó G Jr, Pieri C, Gáspár R Jr, Szöllösi J.

Biophys Chem. 1999 Dec 13;82(2-3):99-108.

PMID:
17030342
35.

Novel calibration method for flow cytometric fluorescence resonance energy transfer measurements between visible fluorescent proteins.

Nagy P, Bene L, Hyun WC, Vereb G, Braun M, Antz C, Paysan J, Damjanovich S, Park JW, Szöllősi J.

Cytometry A. 2005 Oct;67(2):86-96.

36.

Detection of receptor trimers on the cell surface by flow cytometric fluorescence energy homotransfer measurements.

Bene L, Szöllosi J, Szentesi G, Damjanovich L, Gáspár R Jr, Waldmann TA, Damjanovich S.

Biochim Biophys Acta. 2005 Jun 30;1744(2):176-98. Epub 2005 Mar 2.

37.

Low levels of antibodies against E. coli and mycobacterial 65kDa heat shock proteins in patients with inflammatory bowel disease.

Huszti Z, Bene L, Kovács A, Fekete B, Füst G, Romics L, Singh M, Prohászka Z.

Inflamm Res. 2004 Oct;53(10):551-5.

PMID:
15597150
38.

Nanoparticle energy transfer on the cell surface.

Bene L, Szentesi G, Mátyus L, Gáspár R, Damjanovich S.

J Mol Recognit. 2005 May-Jun;18(3):236-53.

PMID:
15593286
39.

Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein.

Bacso Z, Nagy H, Goda K, Bene L, Fenyvesi F, Matkó J, Szabó G.

Cytometry A. 2004 Oct;61(2):105-16.

40.

Detection of channel proximity by nanoparticle-assisted delaying of toxin binding; a combined patch-clamp and flow cytometric energy transfer study.

Rubovszky B, Hajdú P, Krasznai Z, Gáspár R Jr, Waldmann TA, Damjanovich S, Bene L.

Eur Biophys J. 2005 Mar;34(2):127-43.

PMID:
15375639
41.

A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations.

Ulrichts H, Harsfalvi J, Bene L, Matko J, Vermylen J, Ajzenberg N, Baruch D, Deckmyn H, Tornai I.

J Thromb Haemost. 2004 Sep;2(9):1622-8.

42.

Membrane topography of HLA I, HLA II, and ICAM-1 is affected by IFN-gamma in lipid rafts of uveal melanomas.

Bene L, Bodnár A, Damjanovich S, Vámosi G, Bacsó Z, Aradi J, Berta A, Damjanovich J.

Biochem Biophys Res Commun. 2004 Sep 17;322(2):678-83.

PMID:
15325283
43.

Partial protection against dextran sodium sulphate induced colitis in histamine-deficient, histidine decarboxylase knockout mice.

Bene L, Sápi Z, Bajtai A, Buzás E, Szentmihályi A, Arató A, Tulassay Z, Falus A.

J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):171-6.

PMID:
15269623
44.

Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Schönlein purpura.

Novák J, Szekanecz Z, Sebesi J, Takáts A, Demeter P, Bene L, Sipka S, Csiki Z.

Autoimmunity. 2003 Aug;36(5):307-11.

PMID:
14567560
45.

High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.

Bene L, Füst G, Fekete B, Kovács A, Horváth L, Prohászka Z, Miklós K, Pálos G, Daha M, Farkas H, Varga L.

Dig Dis Sci. 2003 Jun;48(6):1186-92.

PMID:
12822883
46.

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G.

Immunogenetics. 2003 Jul;55(4):247-52. Epub 2003 Jun 14.

PMID:
12811429
47.

[A. Classification of antibiotics. 7/ glycopeptides, cyclines, nitro-imidazoles].

Béné L, Mandy B, Woronoff-Lemsi MC, Belon JP.

Soins. 2003 Mar;(673):53-4. French. No abstract available.

PMID:
12677928
48.

Signal transduction in T lymphocytes and aging.

Damjanovich S, Gáspár R Jr, Bene L, Jenei A, Mátyus L.

Exp Gerontol. 2003 Mar;38(3):231-6. Review.

PMID:
12581786
49.

New trends in studying structure and function of biological membranes.

Damjanovich S, Vámosi G, Bodnár A, Bene L.

Acta Physiol Hung. 2002;89(4):415-25. Review.

PMID:
12489751
50.

Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease.

Bene L, Füst G, Huszti Z, Hernádi Z, Fekete B, Mészáros M, Veres A, Kovács A, Miklós K, Singh M, Romics L, Prohászka Z.

Dig Dis Sci. 2002 Jul;47(7):1432-7.

PMID:
12141797

Supplemental Content

Support Center